Related references
Note: Only part of the references are listed.Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Intratumoral Therapy of Glioblastoma Multiforme Using Genetically Engineered Transferrin for Drug Delivery
Dennis J. Yoon et al.
CANCER RESEARCH (2010)
Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells
Mark T. Howes et al.
JOURNAL OF CELL BIOLOGY (2010)
Folate-Targeted Therapies for Cancer
Wei Xia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma
Sandeep Kunwar et al.
NEURO-ONCOLOGY (2010)
Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics
Marianela Candolfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Folate-targeted therapeutic and imaging agents for cancer
Philip Stewart Low et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
IL-13 receptor-alpha 2: a novel target for cancer therapy
Bharat H. Joshi et al.
IMMUNOTHERAPY (2009)
IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma
Mitomu Kioi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A Role for the Proton-coupled Folate Transporter (PCFT-SLC46A1) in Folate Receptor-mediated Endocytosis
Rongbao Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Epidermal Growth Factor Receptor Ligands at a Glance
Marlon R. Schneider et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins
Dennis J. Yoon et al.
JOURNAL OF CONTROLLED RELEASE (2009)
In Vivo Structural Activity and Optimization Studies of Folate-Tubulysin Conjugates
Joseph A. Reddy et al.
MOLECULAR PHARMACEUTICS (2009)
Improving therapeutic properties of protein drugs through alteration of intracellular trafficking pathways
Bert J. Lao et al.
BIOTECHNOLOGY PROGRESS (2008)
Folate Targeting Enables Durable and Specific Antitumor Responses from a Therapeutically Null Tubulysin B Analogue
Christopher P. Leamon et al.
CANCER RESEARCH (2008)
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
D. A. Vallera et al.
GUT (2008)
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
John H. Sampson et al.
NEURO-ONCOLOGY (2008)
Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145
Christopher P. Leamon et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Preclinical antitumor activity of a novel folate-targeted dual drug conjugate
Christopher P. Leamon et al.
MOLECULAR PHARMACEUTICS (2007)
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate
Joseph A. Reddy et al.
CANCER RESEARCH (2007)
Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates
Jun Yang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Preclinical evaluation of EC145, a folate-Vinca alkaloid conjugate
Joseph A. Reddy et al.
CANCER RESEARCH (2007)
Inhibition of transferrin iron release increases in vitro drug carrier efficacy
Bert J. Lao et al.
JOURNAL OF CONTROLLED RELEASE (2007)
The folate receptor: What does it promise in tissue-targeted therapeutics?
Marcela D'Alincourt Salazar et al.
CANCER AND METASTASIS REVIEWS (2007)
Human reduced folate carrier: translation of basic biology to cancer etiology and therapy
Larry H. Matherly et al.
CANCER AND METASTASIS REVIEWS (2007)
IL-13 receptor isoforms: Breaking through the complexity
Yasuhiro Tabata et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2007)
Synthesis and activity of a folate peptide camptothecin prodrug
Walter A. Henne et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The epidermal growth factor receptor pathway: A model for targeted therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2006)
Interleukin-13 receptor α2 chain -: A potential biomarker and molecular target for ovarian cancer therapy
Mitomu Kioi et al.
CANCER (2006)
Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging
Jun Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Level of expression of IL-13Rα2 impacts receptor distribution and IL-13 signaling
Michael O. Daines et al.
JOURNAL OF IMMUNOLOGY (2006)
Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient
E Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Immunotoxin pharmacokinetics: a comparison of the anti-glioblastoma bi-specific fusion protein (DTAT13) to DTAT and DTIL13
Edward Rustamzadeh et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor
Michael Kraich et al.
BMC BIOLOGY (2006)
Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors
H Shmeeda et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Composition of pH-sensitive triad in C-lobe of human serum transferrin.: Comparison to sequences of ovotransferrin and lactoferrin provides insight into functional differences in iron release
PJ Halbrooks et al.
BIOCHEMISTRY (2005)
The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin
AM Giannetti et al.
STRUCTURE (2005)
Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells
YJ Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Synthesis and biological evaluation of EC72: A new folate-targeted chemotherapeutic
CP Leamon et al.
BIOCONJUGATE CHEMISTRY (2005)
Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma
AP Venook
CANCER (2005)
Integrating cell-level kinetic modeling into the design of engineered protein therapeutics
BM Rao et al.
NATURE BIOTECHNOLOGY (2005)
Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy
H Elnakat et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro
BA Kamen et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Folate receptor endocytosis and trafficking
S Sabharanjak et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Epidermal growth factor receptor: a promising target in solid tumours
JJ Laskin et al.
CANCER TREATMENT REVIEWS (2004)
Pharmacological background of EGFR targeting
L Castillo et al.
ANNALS OF ONCOLOGY (2004)
Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas
M Weaver et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors
JH Sampson et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside
SR Husain et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Cell-level pharmacokinetic model of granulocyte colony-stimulating factor: Implications for ligand lifetime and potency in vivo
CA Sarkar et al.
MOLECULAR PHARMACOLOGY (2003)
Tumor regression mechanisms by IL-13 receptor-targeted cancer therapy involve apoptotic pathways
M Kawakami et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Rational cytokine design for increased lifetime and enhanced potency using pH-activated histidine switching
CA Sarkar et al.
NATURE BIOTECHNOLOGY (2002)
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors
YJ Lu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice
CB Li et al.
PROTEIN ENGINEERING (2002)
Transferrin/transferrin receptor-mediated drug delivery
HY Li et al.
MEDICINAL RESEARCH REVIEWS (2002)
The role of the transferrin-transferrin-receptor system in drug delivery and targeting
HY Li et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Growth factor-induced cell motility in tumor invasion
A Wells et al.
ACTA ONCOLOGICA (2002)
Lactoferrin and transferrin: Functional variations on a common structural framework
EN Baker et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2002)
Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells
M Kawakami et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells
M Brigotti et al.
FASEB JOURNAL (2002)
Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking
P Burke et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
The interleukin-13 receptor α2 chain:: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway
K Kawakami et al.
BLOOD (2001)
Regulation of receptor tyrosine kinase signaling by endocytic trafficking
HS Wiley et al.
TRAFFIC (2001)
Share Paper
